Status:
UNKNOWN
Screening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness Analysis
Lead Sponsor:
Assuta Hospital Systems
Collaborating Sponsors:
Maccabi Healthcare Services, Israel
Conditions:
Latent Tuberculosis Infection
Eligibility:
All Genders
18+ years
Brief Summary
The ministry of health in Israel requires all health-care workers to undergo screening for latent Tuberculosis infection (LTBI) prior to starting work. This is based on the Mantoux skin test, which is...
Eligibility Criteria
Inclusion
- Health care worker undergoing screening for LTBI
Exclusion
- Previous tuberculosis or treatment for LTBI
- Immunosuppressed due to drug treatment, HIV, organ transplant
- Recent TB contacts
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00449345
Start Date
May 1 2007
Last Update
May 30 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Community Tuberculosis service
Rehovot, Israel